Citius Oncology
Price & Volume
Stats
See moreOpen | $1.04 |
Previous Close | $1.03 |
Day Range | $1.02-$1.07 |
52W Range | $0.55-$6.19 |
Market Cap | $95.8M |
Shares Short | 650,544 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.34 |
News
See moreYahoo Finance • 27 days ago
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
Yahoo Finance • 30 days ago
Citius Oncology rises after U.S. launch of Lymphir as a cancer treatment
Yahoo Finance • 2 months ago
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences
Yahoo Finance • 4 months ago
Citius Oncology deploys AI platform to support LYMPHIR launch
About
CEO | Mr. Leonard L. Mazur |
Address | 11 Commerce Drive, Cranford, NJ, United States, 07016 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 0 |
